DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tasisulam is an investigational drug.
There have been 11 clinical trials for Tasisulam. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Melanoma, Neoplasms, and Lung Neoplasms. The leading clinical trial sponsors are Eli Lilly and Company and [disabled in preview].
Recent Clinical Trials for Tasisulam
|A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients||Eli Lilly and Company||Phase 1|
|A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma||Eli Lilly and Company||Phase 1|
|A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma||Eli Lilly and Company||Phase 3|